Brazilian regulator Anvisa had in March denied a certificate for good manufacturing practices to Bharat Biotech citing certain violations of GMP at Bharat Biotech facility. Anvisa’s clearance is a necessary step for the country’s process of authorising this vaccine for emergency use.Bharat Biotech submits fresh request before Brazilian regulator for Covaxin GMP certificate
Brazilian regulator Anvisa had in March denied a certificate for good manufacturing practices to Bharat Biotech citing certain violations of GMP at Bharat Biotech facility. Anvisa’s clearance is a necessary step for the country’s process of authorising this vaccine for emergency use.
Subscribe to:
Post Comments (Atom)
-
The company did not export units last month while it had dispatched 804 Etios units in in June 2019.
-
Google has tried for years to get Samsung, the world#39;s leading mobile device maker by units sold, to drop its own services and give grea...
-
The company, one of the leading manufacturers of soda ash, had initiated the process of carving out its textiles business into GHCL Textile...
No comments:
Post a Comment